HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 69 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,689 | +41.2% | 690 | 0.0% | 0.00% | – |
| Q2 2023 | $8,280 | -24.7% | 690 | -18.3% | 0.00% | – |
| Q1 2023 | $11,002 | -70.3% | 845 | -66.3% | 0.00% | – |
| Q4 2022 | $37,024 | +68.3% | 2,505 | +0.4% | 0.00% | – |
| Q3 2022 | $22,000 | -51.1% | 2,495 | -30.4% | 0.00% | – |
| Q2 2022 | $45,000 | -35.7% | 3,587 | -2.7% | 0.00% | – |
| Q1 2022 | $70,000 | +100.0% | 3,687 | +270.9% | 0.00% | – |
| Q4 2021 | $35,000 | -12.5% | 994 | -8.6% | 0.00% | – |
| Q3 2021 | $40,000 | -25.9% | 1,088 | -20.4% | 0.00% | – |
| Q2 2021 | $54,000 | +42.1% | 1,366 | +1.9% | 0.00% | – |
| Q1 2021 | $38,000 | -9.5% | 1,341 | +2.8% | 0.00% | – |
| Q4 2020 | $42,000 | 0.0% | 1,305 | 0.0% | 0.00% | – |
| Q3 2020 | $42,000 | +740.0% | 1,305 | +650.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 174 | -21.3% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 221 | +30.8% | 0.00% | – |
| Q4 2019 | $4,000 | – | 169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |